News

Reportedly, the US and Chinese governments have approved H1N1 vaccines for use, which will begin next month. The UK government has also reported that the immunisation program is

GlaxoSmithKline has engaged Lazard and Co. with an intention to expand in India. Lazard and Co. will evaluate potential acquisitions in Inida. GSK is reportedly more interested in

Chongqing Jinshan Science & Technology has announced that it is working with IBM as it transforms from a traditional medical device supplier to a provider of medical and

The Medical Research Council (MRC), a UK-based, publicly-funded organization has presented the initial results of the independent phase III COINa study, which did not meet its primary endpoint

Central Drugs Standard Control Organization (CDSCO) in the Karnataka has set up a new office, which brings relief to the pharmaceutical companies. Now the state has two CDSCO

TAKE Solutions, a supply chain management and life sciences products company, has signed a deal with Chennai-based Novel Therapeutics. Reportedly, this is TAKE Solutions’ first deal in Chennai

Merck Serono, a division of Germany-based Merck, has announced that Erbitux (cetuximab) has demonstrated a significant improvement in overall survival (OS) when added to standard 1st-line chemotherapy for

Plexxikon has reported encouraging clinical data from a phase 1 extension study of PLX4032 (RG7204) in metastatic melanoma patients, which expand the results announced from the initial phase

Zandu Pharmaceutical has announced that the company has received approval from the shareholders for merger with Emami and Emami Infrastructure. Zandu Pharmaceutical had conducted ameeting with the company’s